4//SEC Filing
Manion Douglas J. 4
Accession 0001209191-23-044445
CIK 0001557746other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:24 PM ET
Size
9.0 KB
Accession
0001209191-23-044445
Insider Transaction Report
Form 4
Manion Douglas J.
Pres and COO
Transactions
- Tax Payment
Common Stock
2023-08-01$9.81/sh−4,437$43,527→ 23,938 total - Exercise/Conversion
Restricted Stock Units
2023-08-01−15,575→ 46,725 total→ Common Stock (15,575 underlying) - Exercise/Conversion
Common Stock
2023-08-01+15,575→ 28,375 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
- [F3]The shares underlying these restricted stock units vest in four equal annual installments beginning on August 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001875875
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:24 PM ET
- Size
- 9.0 KB